Drug intelligence / Profile preview

Butabarbital

Development stage
Unknown
Lead developer
Viatris
Modality
Small Molecules
Administration
Oral
01

Overview

Butabarbital is a barbiturate drug with sedative and hypnotic properties, primarily used for the short-term treatment of insomnia and to alleviate anxiety, including pre-surgical anxiety. It functions as a non-selective central nervous system depressant by enhancing the inhibitory effects of gamma-aminobutyric acid (GABA) at the GABA-A receptor, which prolongs chloride ion channel opening and leads to neuronal hyperpolarization. Additionally, it directly inhibits AMPA-type glutamate receptors and neuronal acetylcholine receptors, thereby suppressing excitatory neurotransmission. Butabarbital has a relatively fast onset and intermediate duration of action, and it is classified as a Schedule III controlled substance due to its potential for abuse and dependence.

Brand names
ButisolButisol SodiumButalanButicapsSarisolButabarbMebutal
Other names
secbutobarbitone sodiumButabarbitoneSecbutabarbitalSecbutabarbital SodiumSecbutobarbitoneSecumalum
02

Targets

AMPAR (AMPA receptor)GABRR (GABA-A receptor subunit rho)Nicotinic Acetylcholine Receptor

Beyond the preview

Go deeper on Butabarbital.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Butabarbital.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call